Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-003937
Filing Date
2018-03-27
Accepted
2018-03-27 08:01:17
Documents
72
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1645183
2 ex31-1.htm EX-31.1 11936
3 ex31-2.htm EX-31.2 11880
4 ex32-1.htm EX-32.1 7512
5 ex32-2.htm EX-32.2 7574
  Complete submission text file 0001493152-18-003937.txt   4933394

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20171231.xml EX-101.INS 629108
7 XBRL SCHEMA FILE cdxi-20171231.xsd EX-101.SCH 54229
8 XBRL CALCULATION FILE cdxi-20171231_cal.xml EX-101.CAL 54666
9 XBRL DEFINITION FILE cdxi-20171231_def.xml EX-101.DEF 165767
10 XBRL LABEL FILE cdxi-20171231_lab.xml EX-101.LAB 392977
11 XBRL PRESENTATION FILE cdxi-20171231_pre.xml EX-101.PRE 288417
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

EIN.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-181719 | Film No.: 18714121
SIC: 2834 Pharmaceutical Preparations